Canton Strategic Holdings, Inc.

Canton Strategic Holdings, Inc. is a publicly traded company listed on Nasdaq under the ticker CNTN [2]. The company maintains its headquarters at 1460 Broadway, New York, NY, 10036 [1]. According to SEC classification, Canton Strategic Holdings operates in the finance services industry [3]. The company was previously registered with the SEC under the name Hillstream BioPharma Inc. from May 2021 to September 2023 [5], and subsequently as Tharimmune, Inc. from September 2023 to February 2026 [4]. In its most recent annual report, the company reported total assets of $519.1 million [6].

Something wrong or missing? Send a correction. Fixed within 24 hours.